BACKGROUND: Most studies on adolescent screening, brief intervention, and referral to treatment (SBIRT) have examined substance use outcomes. However, it may also impact service use and comorbidity-an understudied topic. We address this gap by examining effects of SBIRT on health care use and comorbidities. METHODS: In a randomized trial sample, we assessed 3 SBIRT care modalities: (1) pediatrician-delivered, (2) behavioral clinician-delivered, and (3) usual. Medical comorbidity and health care use were compared between a brief-intervention group with access to SBIRT for behavioral health (combined pediatrician and behavioral clinician arms) and a group without (usual care) over 1 and 3 years. RESULTS: Among a sample of eligible adolescents (n = 1871), the SBIRT group had fewer psychiatry visits at 1 year (incidence rate ratio [iRR] = 0.76; P = .05) and 3 years (iRR = 0.65; P < .05). Total outpatient visits did not differ in year 1. The SBIRT group was less likely to have mental health diagnoses (odds ratio [OR] = 0.69; 95% confidence interval [CI] = 0.48-1.01) or chronic conditions (OR = 0.66; 95% CI = 0.45-0.98) at 1 year compared with those in usual care. At 3 years, the SBIRT group had fewer total outpatient visits (iRR = 0.85; P < .05) and was less likely to have substance use diagnoses (OR = 0.64; 95% CI = 0.45-0.91) and more likely to have substance use treatment visits (iRR = 2.04; P < .01). CONCLUSIONS: Providing SBIRT in pediatric primary care may improve health care use and health, mental health, and substance use outcomes. We recommend further exploring the effects of SBIRT on these outcomes.
RCT Entities:
BACKGROUND: Most studies on adolescent screening, brief intervention, and referral to treatment (SBIRT) have examined substance use outcomes. However, it may also impact service use and comorbidity-an understudied topic. We address this gap by examining effects of SBIRT on health care use and comorbidities. METHODS: In a randomized trial sample, we assessed 3 SBIRT care modalities: (1) pediatrician-delivered, (2) behavioral clinician-delivered, and (3) usual. Medical comorbidity and health care use were compared between a brief-intervention group with access to SBIRT for behavioral health (combined pediatrician and behavioral clinician arms) and a group without (usual care) over 1 and 3 years. RESULTS: Among a sample of eligible adolescents (n = 1871), the SBIRT group had fewer psychiatry visits at 1 year (incidence rate ratio [iRR] = 0.76; P = .05) and 3 years (iRR = 0.65; P < .05). Total outpatient visits did not differ in year 1. The SBIRT group was less likely to have mental health diagnoses (odds ratio [OR] = 0.69; 95% confidence interval [CI] = 0.48-1.01) or chronic conditions (OR = 0.66; 95% CI = 0.45-0.98) at 1 year compared with those in usual care. At 3 years, the SBIRT group had fewer total outpatient visits (iRR = 0.85; P < .05) and was less likely to have substance use diagnoses (OR = 0.64; 95% CI = 0.45-0.91) and more likely to have substance use treatment visits (iRR = 2.04; P < .01). CONCLUSIONS: Providing SBIRT in pediatric primary care may improve health care use and health, mental health, and substance use outcomes. We recommend further exploring the effects of SBIRT on these outcomes.
Authors: Rebecca M Cunningham; Stephen T Chermack; Marc A Zimmerman; Jean T Shope; C Raymond Bingham; Frederic C Blow; Maureen A Walton Journal: Pediatrics Date: 2012-05-21 Impact factor: 7.124
Authors: Robert J Tait; Lucinda Teoh; Erin Kelty; Elizabeth Geelhoed; David Mountain; Gary K Hulse Journal: Drug Alcohol Depend Date: 2016-06-11 Impact factor: 4.492
Authors: Janice L Pringle; David K Kelley; Shannon M Kearney; Arnie Aldridge; William Dowd; William Johnjulio; Arvind Venkat; Michael Madden; John Lovelace Journal: Med Care Date: 2018-02 Impact factor: 2.983
Authors: Nora D Volkow; James M Swanson; A Eden Evins; Lynn E DeLisi; Madeline H Meier; Raul Gonzalez; Michael A P Bloomfield; H Valerie Curran; Ruben Baler Journal: JAMA Psychiatry Date: 2016-03 Impact factor: 21.596
Authors: Francis Vergunst; Nicholas Chadi; Massimiliano Orri; Camille Brousseau-Paradis; Natalie Castellanos-Ryan; Jean R Séguin; Frank Vitaro; Daniel Nagin; Richard E Tremblay; Sylvana M Côté Journal: Eur Child Adolesc Psychiatry Date: 2021-05-31 Impact factor: 4.785
Authors: Carolina Barbosa; Alexander Cowell; Laura Dunlap; Brendan Wedehase; Kristi Dušek; Robert P Schwartz; Jan Gryczynski; Alan Barnosky; Arethusa S Kirk; Marla Oros; Colleen Hosler-Moore; Kevin E O'Grady; Barry S Brown; Shannon Gwin Mitchell Journal: J Stud Alcohol Drugs Date: 2022-03 Impact factor: 2.582
Authors: Derek D Satre; Sujaya Parthasarathy; Kelly C Young-Wolff; Meredith C Meacham; Brian Borsari; Matthew E Hirschtritt; Lucas Van Dyke; Stacy A Sterling Journal: J Stud Alcohol Drugs Date: 2022-09 Impact factor: 3.346
Authors: Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz; Arethusa S Kirk; Kristi Dusek; Marla Oros; Colleen Hosler; Kevin E O'Grady; Barry S Brown Journal: J Subst Abuse Treat Date: 2020-01-20
Authors: Sarah J Beal; Constance A Mara; Katie Nause; Robert T Ammerman; Rebecca Seltzer; Melissa Jonson-Reid; Mary V Greiner Journal: Acad Pediatr Date: 2021-05-21 Impact factor: 3.107